Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
Clinical trial NCT05614778 · COMPLETED
Trial details
- NCT number
- NCT05614778
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-28
- Primary completion
- 2024-02-01
- Enrollment
- 2881
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.